Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022 Aug 19, 2022 01:00AM
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients Apr 28, 2022 01:00AM
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients Apr 28, 2022 01:00AM
Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients Feb 28, 2022 01:00AM
Vifor Pharma supports Iron Deficiency Day 2021: Call to action for early iron deficiency diagnosis Nov 26, 2021 01:00AM


Nov 26, 2020 01:00AM Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality
Nov 26, 2019 02:00AM Vifor Pharma raises awareness on Iron Deficiency Day 2019 for people around the world to take iron seriously
Nov 6, 2019 01:00AM Vifor Pharma and Evotec form joint venture for early development in nephrology